Ligand Portfolio

We believe Ligand has assembled one of the largest portfolio of assets among its biotech peers with over 90 fully funded partnered programs.

The portfolio covers a diverse array of indications with many programs in late stages of development.



Pie Chart
Distribution of Therapeutic Areas
Oncology37%
CNS10%
Inflammation16%
Metabolic Disease10%
Blood Disorder8%
Anti-microbial3%
Anti-viral4%
Cardiology4%
Other8%
Distribution of Partners
GSK8
Viking Therapeutics5
Merck4
Pfizer4
BMS4
AstraZeneca4
Eli Lilly4
Sanofi Aventis2



 

 

Site 'Main' Navigation: